The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Perspective Therapeutics Inc shares valued at $39,500 were purchased by Mark Austin on Sep 12 ’24. At $15.80 per share, Mark Austin acquired 2,500 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hunt Jonathan Robert purchased 1,800 shares, netting a total of over 17,667 in proceeds. Following the buying of shares at $9.81 each, the insider now holds 35,971 shares.
Before that, Woods Lori A had added 4,587 shares to its account. In a trade valued at $49,990, the Director bought Perspective Therapeutics Inc shares for $10.90 each. Upon closing the transaction, the insider’s holdings increased to 4,587 shares, worth approximately $2.11 million.
As published in their initiating research note from Wedbush on October 01, 2024, Perspective Therapeutics Inc [CATX] has been an Outperform and the price target has been revised to $25. Analysts at Truist started covering the stock with ‘”a Buy”‘ outlook in a report released in late September. As of July 25, 2024, BofA Securities has initiated its “Buy” rating for CATX. Earlier on May 09, 2024, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for CATX stock.
Analyzing CATX Stock Performance
During the last five days, there has been a surge of approximately 7.75%. Over the course of the year, Perspective Therapeutics Inc shares have jumped approximately 228.61%. Shares of the company reached a 52-week high of $19.05 on 05/15/24 and a 52-week low of $3.80 on 01/18/24. A 50-day SMA is recorded $13.77, while a 200-day SMA reached $11.78. Nevertheless, trading volume fell to 0.98 million shares from 1.29 million shares the previous day.
Support And Resistance Levels for Perspective Therapeutics Inc (CATX)
According to the 24-hour chart, there is a support level at 12.92, which, if violated, would cause prices to drop to 12.63. In the upper region, resistance lies at 13.45. The next price resistance is at 13.69. RSI (Relative Strength Index) is 47.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.13, which suggests the price will decrease in the coming days. Percent R is at 60.84%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
